253 related articles for article (PubMed ID: 16894525)
1. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia.
Gurney JG; Ness KK; Sibley SD; O'Leary M; Dengel DR; Lee JM; Youngren NM; Glasser SP; Baker KS
Cancer; 2006 Sep; 107(6):1303-12. PubMed ID: 16894525
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
[TBL] [Abstract][Full Text] [Related]
3. Adult survivors of childhood acute lymphoblastic leukaemia with GH deficiency have normal self-rated quality of life but impaired neuropsychological performance 20 years after cranial irradiation.
Link K; Moëll C; Osterberg K; Persson R; Ørbaek P; Garwicz S; Cavallin-Ståhl E; Erfurth EM
Clin Endocrinol (Oxf); 2006 Nov; 65(5):617-25. PubMed ID: 17054463
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
Ham JN; Ginsberg JP; Hendell CD; Moshang T
Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood.
Brennan BM; Rahim A; Mackie EM; Eden OB; Shalet SM
Clin Endocrinol (Oxf); 1998 Jun; 48(6):777-83. PubMed ID: 9713568
[TBL] [Abstract][Full Text] [Related]
6. Prolactin insufficiency but normal thyroid hormone levels after cranial radiotherapy in long-term survivors of childhood leukaemia.
Follin C; Link K; Wiebe T; Moëll C; Björk J; Erfurth EM
Clin Endocrinol (Oxf); 2013 Jul; 79(1):71-8. PubMed ID: 23167807
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone deficiency and neurocognitive function in adult survivors of childhood acute lymphoblastic leukemia.
Krull KR; Li C; Phillips NS; Cheung YT; Brinkman TM; Wilson CL; Armstrong GT; Khan RB; Merchant TE; Sabin ND; Srivastava D; Pui CH; Robison LL; Hudson MM; Sklar CA; Chemaitilly W
Cancer; 2019 May; 125(10):1748-1755. PubMed ID: 30690723
[TBL] [Abstract][Full Text] [Related]
8. Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study.
Schmiegelow M; Lassen S; Poulsen HS; Feldt-Rasmussen U; Schmiegelow K; Hertz H; Müller J
Clin Endocrinol (Oxf); 2000 Aug; 53(2):191-7. PubMed ID: 10931100
[TBL] [Abstract][Full Text] [Related]
9. Young adult survivors of childhood acute lymphoblastic leukemia: spontaneous GH secretion in relation to CNS radiation.
Jarfelt M; Bjarnason R; Lannering B
Pediatr Blood Cancer; 2004 Jun; 42(7):582-8. PubMed ID: 15127412
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Effect of Cranial Radiotherapy on Pituitary-Hypothalamus Area in Childhood Acute Lymphoblastic Leukemia Survivors.
Follin C; Erfurth EM
Curr Treat Options Oncol; 2016 Sep; 17(9):50. PubMed ID: 27476159
[TBL] [Abstract][Full Text] [Related]
11. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.
Follin C; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2006 May; 91(5):1872-5. PubMed ID: 16522695
[TBL] [Abstract][Full Text] [Related]
12. Growth and growth hormone secretion after treatment for acute lymphoblastic leukemia in childhood. 18-Gy versus 24-Gy cranial irradiation.
Stubberfield TG; Byrne GC; Jones TW
J Pediatr Hematol Oncol; 1995 May; 17(2):167-71. PubMed ID: 7749768
[TBL] [Abstract][Full Text] [Related]
13. Body composition in young adult survivors of childhood acute lymphoblastic leukaemia.
Jarfelt M; Lannering B; Bosaeus I; Johannsson G; Bjarnason R
Eur J Endocrinol; 2005 Jul; 153(1):81-9. PubMed ID: 15994749
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia.
Hoorweg-Nijman JJ; Kardos G; Roos JC; van Dijk HJ; Netelenbos C; Popp-Snijders C; de Ridder CM; Delemarre-van de Waal HA
Clin Endocrinol (Oxf); 1999 Feb; 50(2):237-44. PubMed ID: 10396368
[TBL] [Abstract][Full Text] [Related]
15. A novel variant of growth hormone (GH) insufficiency following low dose cranial irradiation.
Crowne EC; Moore C; Wallace WH; Ogilvy-Stuart AL; Addison GM; Morris-Jones PH; Shalet SM
Clin Endocrinol (Oxf); 1992 Jan; 36(1):59-68. PubMed ID: 1559301
[TBL] [Abstract][Full Text] [Related]
16. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.
Odame I; Duckworth J; Talsma D; Beaumont L; Furlong W; Webber C; Barr R
Pediatr Blood Cancer; 2006 Mar; 46(3):357-62. PubMed ID: 16035080
[TBL] [Abstract][Full Text] [Related]
17. Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity?
Brennan BM; Rahim A; Blum WF; Adams JA; Eden OB; Shalet SM
Clin Endocrinol (Oxf); 1999 Feb; 50(2):163-9. PubMed ID: 10396357
[TBL] [Abstract][Full Text] [Related]
18. The utility of the growth hormone (GH) releasing hormone-arginine test for diagnosing GH deficiency in adults with childhood acute lymphoblastic leukemia treated with cranial irradiation.
Björk J; Link K; Erfurth EM
J Clin Endocrinol Metab; 2005 Nov; 90(11):6048-54. PubMed ID: 16131575
[TBL] [Abstract][Full Text] [Related]
19. Associations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial Radiotherapy.
Follin C; Gabery S; Petersén Å; Sundgren PC; Björkman-Burtcher I; Lätt J; Mannfolk P; Erfurth EM
PLoS One; 2016; 11(1):e0147575. PubMed ID: 26824435
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors.
Hata M; Ogino I; Aida N; Saito K; Omura M; Kigasawa H; Toyoda Y; Tachibana K; Matsubara S; Inoue T
Int J Cancer; 2001; 96 Suppl():117-24. PubMed ID: 11992395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
